Month: June 2014

U.S. leasing company Air Lease Corp is interested in a possible upgraded version of European planemaker Airbus Group's A330 passenger jet, a senior company executive said on Sunday. "Yes we are interested in that airplane," President and Chief Operating Officer John Plueger told Reuters on the sidelines of an IATA airline industry meeting in Doha. Airbus has not decided whether to go ahead with the re-engined version of its most popular wide-body model amid an ongoing internal debate about whether to continue to offer it with more than one choice of engine, industry sources have said. Plueger and other industry executives said the price of the aircraft would be a decisive factor in the success of the "A330neo", as Airbus seeks to overcome the lower operating costs of the newer Boeing 787-10 with lower up-front ownership costs.

By Julie Steenhuysen CHICAGO (Reuters) – U.S. researchers are finalizing plans to test two immunotherapy drugs made by Bristol-Myers Squibb Co on patients newly diagnosed with the most common form of deadly brain tumors in adults. Dr. Mark Gilbert, a leading brain tumor researcher at University of Texas MD Anderson Cancer Center in Houston, said he got approval last Tuesday from the National Cancer Institute (NCI) to start designing the trial, likely to begin this fall, with the melanoma drug Yervoy and an experimental drug called nivolumab. The trial will be run through the nonprofit NRG Oncology, an NCI sponsored cooperative group of cancer researchers. “We’re really excited about them,” said Gilbert, who spoke in an interview at the American Society of Clinical Oncology meeting in Chicago.

WASHINGTON (AP) — Details of a refashioned bill to address the problems plaguing the federally run veterans' health care system were released Sunday by its sponsor, the chairman of the Senate Veterans Affairs Committee.